CAMP 8-K 2026-09-28
Camp4 Therapeutics Corp (CAMP) 8-K dated 2026-09-28 — accession 0001628280-26-063740.
Camp4 Therapeutics Corp (CAMP) is a biotechnology company listed on NASDAQ.
Camp4 Therapeutics Corp filed a 8-K on 2026-09-28. Accession 0001628280-26-063740.
This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported CAMP revenue for 2025-12-31 was $3.5M. Net income was -$80.4M. Revenue was up 436.5% from 2024-12-31 to 2025-12-31. CAMP currently screens at market cap $215.0M.
Not investment advice. The CAMP SEC hub lists recent forms. The stock page is the research view.